EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Naringin in cholestatic liver ischemia-reperfusion injury

Arif Aslaner, Kemal Eyvaz, Erhan Aydemir, Şenay Yıldırım, Kübra Kılıç Kartal, Hamit Yaşar Ellidağ, Uğur Doğan

Acta Cirúrgica Brasileira · 2025

DOI: 10.1590/acb404225 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Acta Cirúrgica Brasileira, 2025. Verfasst von Arif Aslaner und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Sciences - Antalya Training and Research Hospital - Department of Organ Transplantation - Antalya, Turkey. Hauptthemen laut MEDLINE: Reperfusion Injury, Flavanones, Liver, Cholestasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the potential protective effects of naringin on liver by oxidative parameters and signal peptide-CUB-EGF-like domain-containing protein (SCUBE)-1 and 2 in an experimental cholestatic liver ischemia reperfusion (IR) model.

Methods

Twenty-four female rats were divided into three groups; sham, control, and treatment. Groups 2 and 3 underwent bile duct ligation, and one week later, 45 min of ischemia and 1 hour of relaparotomy and reperfusion were performed. To the treatment group, naringin was administered through relaparotomy. Liver tissue and blood samples were taken. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin (TBIL), direct bilirubin (DBIL), ischemia-modified albumin (IMA), SCUBE-1, SCUBE-2, total antioxidant status (TAS), and total oxidant status (TOS) levels were also examined.

Results

Serum ALT, AST, ALP, TBIL, DBIL, and IMA levels were higher in groups 2 and 3. There was no significant difference in terms of SCUBE-1 and 2 levels (p > 0.05). TAS was the highest in group 3, and TOS was the highest in group 2 and lower in group 3. In histopathological analysis, all parameters were statistically significant between group 3 and the other groups (p < 0.05).

Conclusion

Naringin has promising results in the treatment of experimental IR injury in cholestatic liver due to its antioxidant effects. We think that it can be used in clinical studies after more comprehensive studies investigating its effects on IR damage in cholestatic liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryFlavanonesLiverCholestasisAntioxidantsAnimalsFemaleDisease Models, AnimalOxidative StressAlanine TransaminaseAspartate AminotransferasesRats, WistarRatsBilirubinAlkaline Phosphatase

Substanzen

naringinFlavanonesAntioxidantsAlanine TransaminaseAspartate AminotransferasesBilirubinAlkaline Phosphatase

Autor:innen und Institutionen

  • University of Health Sciences - Antalya Training and Research Hospital - Department of Organ Transplantation - Antalya, Turkey.
  • University of Health Sciences - Antalya Training and Research Hospital - Department of General Surgery - Antalya, Turkey.
  • University of Health Sciences - Antalya Training and Research Hospital - Department of Pathology - Antalya, Turkey.
  • University of Health Sciences - Antalya Training and Research Hospital - Department of Medical Biochemistry - Antalya, Turkey.

Zitieren

APA

Aslaner, A., Eyvaz, K., Aydemir, E., Yıldırım, Ş., Kartal, K. K., Ellidağ, H. Y., & Doğan, U. (2025). Naringin in cholestatic liver ischemia-reperfusion injury. Acta Cirúrgica Brasileira. https://doi.org/10.1590/acb404225

Vancouver

Aslaner A, Eyvaz K, Aydemir E, Yıldırım Ş, Kartal KK, Ellidağ HY, et al. Naringin in cholestatic liver ischemia-reperfusion injury. Acta Cirúrgica Brasileira. 2025. doi:10.1590/acb404225

BibTeX
@article{Aslaner2025,
  author = {Aslaner, Arif and Eyvaz, Kemal and Aydemir, Erhan and Yıldırım, Şenay and Kartal, Kübra Kılıç and Ellidağ, Hamit Yaşar and Doğan, Uğur},
  title = {Naringin in cholestatic liver ischemia-reperfusion injury},
  journal = {Acta Cirúrgica Brasileira},
  year = {2025},
  doi = {10.1590/acb404225}
}
Kostenlos starten →